SEC Form 4 · accession 0001193125-26-257913
KESTRA MEDICAL TECHNOLOGIES, LTD. · KMTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alfred J Ford Jr.
Officer — Chief Commercial Officer
Period of report
Jun 3, 2026
Accepted (ET)
Jun 4, 2026 · 6:39 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001877184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Jun 3, 2026 | A | 25,227 | $0.00 | A | 74,639 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026.